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a b s t r a c t
The Human papillomavirus (HPV) capsid is composed of the major and minor capsid proteins, L1 and L2,
respectively. Infectious entry requires a complex series of conformational changes in both proteins that
lead to uptake and allow uncoating to occur. During entry, the capsid is disassembled and host
cyclophilins dissociate L1 protein from the L2/DNA complex. Herein, we describe a mutant HPV16 L2
protein (HPV16 L2-R302/5A) that trafﬁcs pseudogenome to the trans-Golgi network (TGN) but fails to
egress. Our data provide further evidence that HPV16 trafﬁcs through the TGN and demonstrates that L2
is essential for TGN egress. Furthermore, we show that cyclophilin activity is required for the L2/DNA
complex to be transported to the TGN which is accompanied by a reduced L1 protein levels.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Human Papillomaviruses (HPV) are non-enveloped epitheliotro-
pic viruses, which are associated with malignancies of the epithelium
including cervical, penile, anogenital, and oropharyngeal carcinoma.
The viral capsid is composed of 360 copies of the major capsid
protein, L1, organized into 72 pentamers, which are also called
capsomeres. Sixty capsomeres are pentavalent, i.e. have ﬁve nearest
neighbors, whereas 12 capsomeres are hexavalent (Chen et al., 2000;
Finch and Klug, 1965). Capsomeres are interconnected by invading C-
terminal arms, which are stabilized by intercapsomeric disulﬁde
bonds resulting in covalently linked L1 dimers and trimers (Li et al.,
1998; Mejia et al., 2006; Sapp et al., 1998; Wolf et al., 2010). In
addition, up to 72 copies of the minor capsid protein, L2, are present
within the capsid, mostly hidden inside with only a short N-terminal
portion accessible (Buck et al., 2008; Liu et al., 1997; Modis et al.,
2002). The protein shell encapsidates a circular, double-stranded
DNA viral genome of about 8000 bp, which is organized into
chromatin (Favre et al., 1977).
Recent advances in understanding the HPV16 internalization
process was based on the development of systems to generate
pseudovirions, which mimic authentic particles (Buck et al., 2004,
2005a) that also encapsidate a pseudogenome. Using these particles,
it was demonstrated that HPV16 particles attach to the extracellular
matrix via primary heparin sulfate proteoglycan receptors using L1
lysine residues 278 and 361 present on capsomeres (Knappe et al.,
2007). Attachment triggers conformational changes in both capsid
proteins allowing transfer to unknown secondary receptors and
infectious internalization (Day et al., 2008; Richards et al., 2013;
Selinka et al., 2007; Spoden et al., 2008). These processes are
extremely slow and asynchronous, taking several hours to complete
(Christensen et al., 1995; Giroglou et al., 2001; Smith et al., 2007).
Infectious internalization of HPV16 occurs via a clathrin- and
caveolae-independent pathway (Spoden et al., 2008, 2013;
Schelhaas et al., 2012). Acidiﬁcation of the endocytic compartment
is essential for successful infection (Day et al., 2003; Selinka et al.,
2002) and is accompanied or followed by uncoating and egress from
endosomes (Kamper et al., 2006), and subsequent accumulation of
incoming pseudogenomes at PML nuclear bodies (Day et al., 2004).
Successful delivery of the pseudogenome to the nucleus depends on
the activity of numerous host cell factors. One such factor, cell surface
cyclophilin B, a chaperone peptidyl-prolyl cis/trans isomerase, facil-
itates exposure of a hidden cleavage site on the N-terminus of the L2
protein that is subsequently cleaved by furin convertase, both events
that have been shown to be required for pseudogenome delivery
(Bienkowska-Haba et al., 2009; Richards et al., 2006). Our lab has
demonstrated that host cell cyclophilins (CyPs) are also required at a
secondary, post-internalization step which mediates the dissociation
of the L1 protein from the L2/DNA complex prior to nuclear entry
(Bienkowska-Haba et al., 2012). The L2 protein mediates egress of the
pseudogenome from endosomes (Kamper et al., 2006) and
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retrograde transport of pseudogenome along microtubules to the
nucleus (Florin et al., 2006; Schneider et al., 2011).
Recently, a genome-wide siRNA screening identiﬁed cellular fac-
tors involved in retrograde trafﬁcking of HPV. Among these factors,
components of the retromer complex and Rab GTPases were found to
be required for retrograde transport of HPV16 pseudovirions to the
trans-Golgi network (TGN) (Day et al., 2013; Lipovsky et al., 2013).
It was demonstrated that HPV16 virions enter the TGN in a retromer-
dependent manner during infectious entry. Additionally, it was also
shown that TGN localization is dependent on furin-cleaved L2 protein
(Day et al., 2013). Following TGN egress, the L2 protein accompanies
the viral genome to PML nuclear bodies (PML NBs) (Day et al., 2004).
Evidence indicates that nuclear import of viral DNA requires nuclear
envelope breakdown (Pyeon et al., 2009) suggesting independence of
active nuclear import pathways despite the existence of redundant
nuclear localization signals (NLS) in L2 (Becker et al., 2003).
The L2 protein has two canonical nuclear localization signals on
both the N- and C-terminal ends. Recently, a third element was
identiﬁed located between amino acids 291–315, which we named
the mNLS, that contain a stretch of arginine residues that were shown
to mediate nuclear retention in vitro (Mamoor et al., 2012). To further
investigate the role of the mNLS in nuclear delivery, our lab has
generated NLS mutants with exchanges in bases within mNLS and
deletions in the N- and C-terminal NLSs. Using transfection and over-
expression, we show that neither NLS is required for nuclear
translocation. Additionally, we conﬁrm that the mNLS functions as a
nuclear retention signal in vitro, results that are consistent with a
previous report (Mamoor et al., 2012). In the context of infectious
entry, we show that pseudovirions with mutations in the mNLS
accumulate in the TGN. Our data presented herein provide further
evidence that HPV genomes trafﬁc through the TGN and conﬁrm that
CyPs are essential for transport to the TGN.
Results
Nuclear translocation of HPV16 L2 protein in vivo
Two sequence elements at the N- and C-terminus of HPV16 L2
protein termed nNLS and cNLS, respectively, have been extensively
characterized as putative nuclear localization signals using a variety
of in vitro techniques (Bordeaux et al., 2006; Darshan et al., 2004;
Klucevsek et al., 2006; Mamoor et al., 2012; Sun et al., 1995). In order
to identify NLSs that might be used in vivo during infection and after
synthesis, we deleted these elements and tested the intracellular
localization of mutant L2 following transfection of expression plas-
mids. The truncations were kept short to minimize potential effects
on L2 protein folding. All transfected mutant L2 constructs were
expressed in HeLa cells (Fig. 1F). As shown in Fig. 1A and G, deletion
of both signals did not abrogate nuclear import of HPV16 L2 protein
suggesting that neither NLS is essential for L2 nuclear translocation.
We therefore concentrated on a third element, which was shown to
inﬂuence intracellular localization of HPV6b (Sun et al., 1995) and
HPV33 L2 (Becker et al., 2003). This region is highly conserved among
members of the Papillomaviridae family Alphapapillomavirus genus
(Fig. 1B). Located between HPV16 L2 amino acid residues 291 and
315, this region contains a number of conserved arginine residues.
We introduced point mutations in this region in the context of full
length and terminally truncated L2 protein focusing on but not
restricted to basic amino acid residues. Replacement of arginine
residues 297, 298, 302, and 305 for alanine affected nuclear localiza-
tionwhen analyzed at 24 hours post-transfection (hptx) of full length
and truncated L2. At this time, a signiﬁcant percentage of mutant L2
protein was found in the cytoplasm. In addition, a varying fraction of
mutant L2 localized to the nucleus in a punctate pattern co-localizing
with PML protein (Fig. 1C). A quantiﬁcation of the results is provided
in Fig. 1G. Additional deletions of the terminal nNLS and cNLS
only had a minor impact on subcellular localization as shown for
16L2-13-455-R297/8-302/5A. These data suggest that the contribu-
tion of nNLS and cNLS to nuclear import is rather negligible under
our conditions. The strongest effect was observed when all four
arginine residues were replaced. However, pronounced reductions in
nuclear import of L2 protein were also found for double mutants
R297/8A and R302/5A (Fig. 1D and G). Exchange of arg-291, lys-309,
arg-315, ser-304, gly-307, or ser-295 and thr-296 for alanine did not
affect nuclear accumulation of L2 protein (data not shown). We also
exchanged arginine residues at positions 295 and 298 of HPV18 L2,
which are homologous to arg-302 and arg-305 of HPV16 L2, and
found that these mutant proteins mainly localize to the cytoplasm as
well at 24 hptx (Fig. 1E and G). Looking at earlier times post-
transfection, we observed wild-type HPV16 L2 localize in the nucleus
as early as 6 hptx and remained nuclear (Fig. 2A) whereas HPV16
mutant L2 protein localized in the nucleus at earlier times post-
transfection (Fig. 2B), but was found to be relocated to the cytoplasm
after 12 hptx. The cytoplasmic relocalization can be abrogated by
inhibiting CRM1-dependent nuclear export with leptomycin B (LMB)
treatment (Fig. 2C). Taken together, these results conﬁrm previous
observations by others (Mamoor et al., 2012) that mutations in this
motif did not abrogate nuclear import but rather affected nuclear
retention.
Characterization of mutant pseudoviruses
In order to investigate the role of this sequence element in context
of infectious HPV entry, pseudoviruses harboring mNLS mutant L2
protein were generated using the 293TT production cell line (Buck et
al., 2004). All tested mutant L2 proteins were efﬁciently incorporated
into pseudoviruses, and all pseudoviruses encapsidated the pEGFP-C1
pseudogenome used for our studies with comparable efﬁciency
(Fig. 3A). We determined the infectivity of the L2 mutants by infecting
293TT and HaCaT cells with mutant pseudovirus for 72 h at 37 1C and
quantiﬁed GFP transcript by real-time PCR (Fig. 3B). The exchange
of arginine 302 and 305 with alanine in the L2 protein rendered the
pseudovirions non-infectious (Fig. 3B). Mutants 16L2-R291A, -S304A,
-G307A, -K309A, and -R315A fully supported infection (data not
shown). Similarly, mutant HPV18 pseudovirus harboring 18L2-R295/
8A was also strongly defective (data not shown) suggesting that the
importance of this region may be conserved among genital high-risk
Papillomaviruses. We assessed the integrity of the capsid structure of
intact virions by measuring reactivity with L1-speciﬁc antibodies by
the enzyme-linked immunosorbent assay (ELISA). Pseudoviruses were
bound for 1 h at 37 1C to wells of an ELISA plate and incubated with
the HPV16 VLP-speciﬁc polyclonal antibody K75, monoclonal antibody
(MAb) 33L1-7 that recognizes a linear epitope of the L1 protein at
amino acids 303 to 313 indicative of disassembly, and MAb H16.V5
that recognizes a conformationally-dependent epitope of the FG loop
of the L1 protein when assembled into capsids (Sapp et al., 1994;
White et al., 1999). We observed comparable reactivity with all three
antibodies between wild-type and mutant pseudoviruses suggesting
that these mutations do not disrupt the capsid structure (Fig. 3C).
Reduced infectivity is not due to deﬁciency in cell binding or
uncoating
To show that the reduction in infectivity is not due to a defect
in cell binding, we bound pseudovirus particles to HaCaT cells
grown on coverslips for 1 h at 37 1C, then ﬁxed and stained using
MAb 33L1-7 following the Click-iT reaction cocktail, which has
previously been shown to denature the capsid protein to make the
linear L1-speciﬁc epitope accessible (Bienkowska-Haba et al.,
2012). We did not observe any difference in the binding of mutant
L2 pseudoviruses compared to the binding of wild-type
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pseudoviruses (Fig. 4A and C). To assess whether there was a
defect in pseudovirus uncoating that could explain our reduction
in infectivity, we infected HaCaT cells with wild-type and mutant
pseudovirus for 18 h at 37 1C. Next, we ﬁxed, permeabilized, and
stained the L1 protein with MAb 33L1-7 without the Click-iT
reaction cocktail and quantiﬁed uncoating relative to wild-type
pseudovirus. The L2 mutants and wild-type pseudovirions exhib-
ited comparable reactivity therefore suggesting that uncoating
was not impacted by these mutations (Fig. 4B and D).
Mutant pseudovirus fails to deliver encapsidated genome to the
nucleus
During infection, the L2 protein delivers the viral genome to the
nucleus where it co-localizes with PML nuclear bodies (Day et al.,
2004). In line with previous ﬁndings, our results from Fig. 1
indicate deletions in the mNLS element of the L2 protein abrogate
nuclear retention of the pseudogenome (Mamoor et al., 2012). Our
infectivity data shows that this region is critical for pseudoinfec-
tion as point mutations in this region render these virions non-
infectious. We next sought to investigate whether virions harbor-
ing this mutant L2 protein are reaching the nucleus. Therefore, we
infected HaCaT cells with wild-type and mutant pseudovirus
carrying EdU-labeled pseudogenome for 24 and 40 h at 37 1C.
The cells were subsequently ﬁxed, permeabilized, and stained
following the Click-iT reaction cocktail. We observed that after 24
and 40 h, the wild-type pseudovirus successfully delivered the
pseudogenome to the nucleus where it co-localizes with PML
protein (Fig. 5A and C). In agreement with previous reports,
pseudogenome was also detected in the cytoplasm indicating that
not all pseudogenomes are delivered to the nucleus (Day et al.,
2004). We were unable to detect any 16L2-R302/5A mutant
pseudogenome in the nucleus at 24 or 40 h (Fig. 5B and D). In
addition, we observed a cytosolic localization of pseudogenome
Fig. 1. in vivo nuclear import of HPV16 L2. (A) Intracellular localization of wt and terminally truncated HPV16 L2 at 24 hptx of HeLa cells. (B) Schematic diagram of L2 and
result of multiple alignment analysis of L2 derived from 93 HPV types. Y axis gives percent conservation. Asterisks indicate fully conserved residues. ((C)–(E)) Intracellular
localization of indicated HPV16 ((C) and (D)) and HPV18 (E) L2 mutants at 24 hptx of HeLa cells. The L2 protein (green), PML protein (red), and actin (blue) were stained. Note
the cytoplasmic accumulation of mNLS point mutant L2 protein. (F) Western blot of indicated wild-type and mutant L2 proteins. (G) Quantitative analysis of intracellular
localization of HPV16 wild-type (A) and indicated L2 mutants ((C) and (D)) with between 50 and 100 cells counted per group. Quantiﬁcation is from one representative
experiment from three biological replicates. N: exclusive nuclear localization; C/N: mainly cytoplasmic and additionally subnuclear PML NB localization.
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delivered by 16L2-R302/5A mutant at both indicated times post-
pseudoinfection.
Pseudogenome passes through the trans-Golgi network during
infectious entry
Our results from Fig. 4 and 5 show that pseudoviral particles
with mutations in the L2 mNLS do not impact cell binding or
uncoating, yet fail to deliver the pseudogenome to the nucleus.
Therefore, we sought to determine where the pseudogenome
delivered by 16L2-R302/5A mutant particles was accumulating
late in the entry process. It was recently reported that the viral
genome passes through the TGN prior to entry into the nucleus
(Day et al., 2013; Lipovsky et al., 2013). To test delivery of
pseudogenome to the TGN, we infected HaCaT cells with wild-
type and mutant pseudovirus carrying EdU-labeled pseudogen-
ome for 18 and 36 h at 37 1C, ﬁxed, permeabilized, and stained the
TGN following the Click-iT reaction cocktail. We quantiﬁed
the number of pseudogenome puncta co-localized with TGN46
(Fig. 6E) and observed that at 18 h, there was comparable co-
localization between mutant and wild-type pseudogenome in the
TGN (Fig. 6A and B). After 36 h, we observed that the majority of
the wild-type pseudogenome has passed through the TGN and is
localized in the nucleus (Fig. 6C). In contrast, pseudogenome
Fig. 2. Intracellular localization of L2 protein at early times post-transfection. (A) Intracellular localization of HPV16 wild-type L2 and (B) indicated mutant L2 at early
times post-transfection of HeLa cells. Note exclusive nuclear localization at early time points, but cytoplasmic distribution at later time points. (C) intracellular localization of
HPV16 L2 wild-type and indicated mutants after 20 h post-transfection of HeLa cells in the presence or absence of 10 ng/ml LMB added to the cells at time 0 hptx.
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delivered by the 16L2-R302/5A mutant pseudovirus accumulated
in the TGN at 36 h (Fig. 6D). These data support the previous
ﬁndings that HPV16 trafﬁcs through the TGN and suggests that
mutating arginine residues within the mNLS element of the L2
protein results in the accumulation of the pseudogenome in
the TGN.
L1 protein accompanies the L2/DNA complex to the TGN at reduced
levels
It is well-established that L2 but not L1 protein accompanies
viral genome to the nucleus. Since this region was previously
shown to bind promiscuously to DNA in vitro (Klucevsek et al.,
2006), we were concerned that mutations in the mNLS element of
the L2 protein may result in a reduced afﬁnity for the pseudogen-
ome. Therefore, we wanted to test whether the L2 protein is
dissociating from the pseudogenome in the TGN. We grew HaCaT
cells on coverslips and infected them with mutant 16L2-R302/5A
pseudovirions carrying EdU-labeled pseudogenome for 36 h and
co-stained for L2, EdU, and TGN46 following the Click-iT reaction
cocktail. We observed pseudogenome co-localizes with mutant
16L2-R302/5A L2 protein in the TGN at 36 h (Fig. 7A) whereas
wild-type L2 was co-localized with pseudogenome in the nucleus
(data not shown). It has been recently shown that L1 protein co-
localizes with TGN makers (Lipovsky et al., 2013). Therefore, next
we asked whether we could also detect L1 protein co-localized
with the pseudogenome in the TGN. To this end, we infected
HaCaT cells with 16L2-R302/5A mutant pseudovirus carrying an
EdU-labeled pseudogenome and stained for L1 and TGN46 at 36 h
following the Click-iT reaction cocktail to denature the capsid
proteins. This was followed by staining with the 33L1-7 antibody
that recognizes a linear epitope of the L1 capsid protein. In order
to allow for quantiﬁcation, we also measured the L1/viral pseu-
dogenome signal strength of viral pseudoparticles bound for 1 h to
ECM and compared EdU-derived signal strength of ECM and TGN-
resident pseudogenome (Fig. 7B). At 1 h, the L1 protein strongly
co-localized with the pseudogenome for both the wild-type (data
not shown) and mutant 16L2-R302/5A pseudovirus (Fig. 7F). After
36 h, the wild-type pseudogenome was predominately localized
to the nucleus where L1 was completely undetectable as expected
(data not shown). However, the TGN-resident pseudogenome
delivered by mutant pseudovirions showed a 75% loss of L1 signal
(Fig. 7C and G) compared to the ECM-resident pseudogenome.
To test whether this loss in signal is due to limitations in the
accessibility of our detection reagents, we measured the peak
signal intensity of EdU puncta at 1 h compared to 36 h within the
TGN. We found no signiﬁcant loss in peak signal intensity (Fig. 7D)
suggesting that we are losing L1 signal within the TGN. Addition-
ally, we observed a complete absence of L1 signal in 38% of TGN-
resident EdU puncta (Fig. 7E and H). Taken together, these data
suggest that the L1 protein is accompanying the pseudogenome to
the TGN in both wild-type and mutant infections, but at greatly
reduced levels.
Cyclophilin activity is required prior to trafﬁcking to the TGN
We have previously shown that cyclophilins are required at
two distinct steps in the entry process. First, cyclophilins mediate
Fig. 3. Characterization of mutant pseudoviruses. (A) The L1 (55 kDa) and L2 (75 kDa) proteins were detected with MAb HPV16 312F and 33L2-1 respectively by Western
blot analysis. The pseudogenome of puriﬁed pseudovirus was detected using real-time PCR and CT values are reported. (B) 293TT and HaCaT cells were infected with HPV16
wild-type, 16L2-R302/5A, and 16L2-R297/8-302/5A pseudoviruses for 72 h and infectivity was measured by quantifying GFP transcript by real-time PCR. (C) A standard ELISA
was performed on HPV16 wild-type (wt), 16L2-R302/5A (302/5), and 16L2-GP-N-R302/5A (GPN-302/5) pseudoviruses against the reactivity of polyclonal antibody anti-L1
K75, MAb anti-L1 33L1-7, and MAb anti-L1 V5 and absorbance was measured at 450 nm.
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the isomerization of the L2 protein on the cell surface to expose
the previously hidden region of L2 encompassing a furin cleavage
site (Bienkowska-Haba et al., 2009). Second, cyclophilins are
required at a post-internalization step to mediate the dissociation
of the L1 protein from the L2/DNA complex prior to trafﬁcking to
the nucleus (Bienkowska-Haba et al., 2012). Since our data from
Fig. 7 showed that L1 protein is present in the TGN at reduced
levels, we asked whether cyclophilin activity was required for
trafﬁcking to the TGN. For this, we used a pseudovirus with
mutations in a putative cyclophilin binding domain at glycine 99
Fig. 4. Reduced infectivity is not due to deﬁciency in cell binding or uncoating. ((A) and (C)) HPV16 wild-type (wt), 16L2-R302/5A (302/5), 16L2-GP-N-R302/5A (GPN-
302/5) pseudoviruses were bound to HaCaT cells for 1 h and detected using MAb 33L1-7 following Click-iT reaction cocktail. The L1 protein (green), cell surface marker
caveolin-1 (red), and nucleus (blue) were stained and pseudovirus binding was quantiﬁed relative to wild-type. ((B) and (D)) HaCaT cells were infected with HPV16 wild-type
(wt), 16L2-R302/5A (302/5), 16L2-GP-N-R302/5A (GPN-302/5) and stained using MAb 33L1-7 without Click-iT reaction cocktail after 18 h to assess uncoating. The L1 protein
(green), actin (purple), and nucleus (blue) were stained. ((C) and (D)) Quantiﬁcation of binding and uncoating was calculated by counting 100 cells (n¼100) in one
representative experiment from two biological replicates.
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and proline 100 that can bypass the surface cyclophilin require-
ment however infect cells comparable to wild-type (Bienkowska-
Haba et al., 2012). Therefore, we introduced the point mutations
arg-302 and arg-305 to generate mutant 16L2-GP-N-R302/5A,
which bypasses the surface cyclophilin requirement, yet accumu-
lates in the TGN. This mutant is non-infectious (data not shown).
We infected HaCaT cells with wild-type and mutant pseudoviruses
carrying EdU-labeled pseudogenomes at 37 1C for 36 h in the
presence or absence of cyclosporine A, a potent inhibitor of
cyclophilins, stained the TGN following the Click-iT reaction cock-
tail, and quantiﬁed the images (Fig. 8D). As expected, in the
absence of cyclosporine A, we found the majority of wild-type
pseudogenome is localized in the nucleus (Fig. 8A) whereas
pseudogenomes delivered by both 16L2-R302/5A (Fig. 8B) and
16L2-GP-N-R302/5A (Fig. 8C) pseudovirions localized in the TGN.
In the presence of cyclosporine A, neither the wild-type nor
mutant pseudogenomes were detectable in the TGN (Fig. 8A–C)
demonstrating that cyclophilin activity is required for successful
trafﬁcking to the TGN. Additionally, we observed noticeably less
pseudogenome present after 36 h in cells treated with cyclospor-
ine A compared to untreated cells. We suspect this loss of EdU
signal is due to degradation of the pseudogenome.
Discussion
Herein, we investigated the role of a highly conserved central
arginine-rich motif within the L2 protein with regard to nuclear
delivery and cytoplasmic trafﬁcking. Using transfection and over-
expression, we showed that deletions of both terminal NLSs did
not signiﬁcantly affect intracellular localization of HPV16 L2
protein. In contrast, mutations in a third arginine-rich stretch of
residues changed the intracellular localization of L2 protein
resulting in a mainly cytoplasmic localization. We selected to
mutate this region because it has homology to the β-like import
receptor binding (BIB) domains, often found in ribosomal proteins,
which are recognized by a number of more recently identiﬁed
import receptors like importin 4, importin 9a and 9b as well as
importin 11. Despite the homology of all three putative L2 NLSs
with known NLSs and their capability to serve as NLSs when fused
to GFP, our data suggest that none of them are being used for L2
nuclear translocation following transfection and over-expression.
That is because we found exclusive localization in the nucleus at
early times post-transfection of an expression cassette encoding L2
protein harboring mutations in all NLSs. We conclude that either
L2 protein harbors an additional unconventional NLS, which does
not require extended stretches of basic amino acid residues, or it
partners with a cellular protein, which provides the NLS. However,
we cannot completely rule out the possibility of passive diffusion
into the nucleus (Mamoor et al., 2012). Since L2 protein again
accumulates in the cytoplasm at later times post-transfection and
inhibitors of the nuclear export factor, CRM1, result in nuclear
rather than cytoplasmic localization of mutant L2 protein, our data
suggest that the mNLS rather functions as a nuclear retention
signal. This is consistent with previously published ﬁndings
(Mamoor et al., 2012).
Since mutations in this central arginine-rich motif did not
negatively affect pseudovirus assembly, we were able to investi-
gate the effect of these mutations on entry and infectivity. It has
been previously demonstrated that this region of 16L2 is essential
for infectivity in both HaCaT cells and in the vaginal mouse model
(Mamoor et al., 2012). We found that exchanges of basic amino
acids within the mNLS did not impair the early steps of HPV16
pseudoinfection like attachment, internalization, and uncoating as
Fig. 5. Nuclear delivery of encapsidated DNA by mutant pseudovirus. HaCaT cells were infected with HPV16 wild-type (wt) and 16L2-R302/5A (302/5) pseudovirus and
stained after 24 h ((A) and (B)) or 40 h ((C) and (D)). PML protein (green), EdU-labeled pseudogenome (red), NUP153 (grey), and the nucleus (blue) were stained following
Click-iT reaction cocktail. Note the cytoplasmic localization of pseudogenome delivered by mutant 16L2-302/5 pseudovirus.
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the pseudogenome as well as the L2 protein was easily detected
within the cell by confocal microscopy. However, some of the
mutant pseudovirions were completely defective for infecting
293TT and HaCaT cells. Non-infectious pseudovirus harboring the
L2 protein with mutations in arg-302 and arg-305 curiously
showed a cytoplasmic distribution of the pseudogenome whereas
wild-type pseudogenome was localizing in the nucleus at PML NB
after 24 h. We noticed that much of the 16L2-R302/5A pseudo-
genome was observed in close proximity to the nucleus. Upon
further investigation, we found that wild-type 16L2 pseudogen-
ome passed through the TGN whereas pseudogenome carried by
16L2-R302/5A mutant pseudovirus trafﬁcked to but was unable to
escape the TGN even after 36 hpi. In line with previous reports by
Day et al. (2013) and Lipovsky et al. (2013), these results provide
further evidence that HPV16 trafﬁcs through the TGN during
infectious entry.
It has been demonstrated that the mNLS of L2, abundant in
positively charged arginine residues, promiscuously binds to DNA
presumably through interacting with the negatively charged
phosphate backbone of DNA (Klucevsek et al., 2006). Therefore,
we thought that it was plausible that mutations in arginine
residues may have resulted in a loss of afﬁnity for the pseudo-
genome and thus it was being lost in the TGN. However, we did
not detect any mutant L2 protein in the nucleus, which was
instead co-localized with the pseudogenome in the TGN. Further-
more, quantiﬁcation did not indicate partial loss of L2 protein from
the pseudoviral genome in the TGN (data not shown). Therefore,
these data suggest that the pseudogenome and the mutant L2
Fig. 6. Pseudogenome passes through the trans-Golgi network during infectious entry. HaCaT cells were infected with wild-type (wt) and 16L2-R302/5A (302/5) for 18 h
((A) and (B)) and 36 h ((C) and (D)). TGN marker TGN46 (cyan), EdU-labeled pseudogenome (red), and nucleus (grey) were stained following Click-iT reaction. (E) Co-
localization of TGN46 and EdU was quantiﬁed as a percentage of total EdU puncta. Statistical signiﬁcance was determined by Student's t-test (po0.0001) where 50 cells
were counted (n¼50). Cells were quantiﬁed from one representative experiment from three biological replicates. Note the accumulation of the pseudogenome co-localized
with the TGN after 36 h.
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Fig. 7. L1 accompanies the L2/DNA complex to the TGN. HaCaT cells were infected with HPV 16L2-R302/5A (302/5) for 1 h (B) or 36 h ((A) and (B)). The L2 protein (green) (A) or L1
protein (green) (B), EdU-labeled pseudogenome (red), TGN46 (cyan), and nucleus (grey) were stained following Click-iT reaction cocktail. (C) Peak signal intensity ratios of L1/EdU at
36 h co-localized with the TGN were quantiﬁed as a percentage of 1 h. Statistical signiﬁcance was determined by Student's t-test (po0.0001). (D) The average peak EdU signal
intensity of 1 h compared to peak EdU signal intensity at 36 h within the TGN as a percentage of 1 h. Note that there is no loss of EdU signal at 1 h compared to 36 h within the TGN.
(E) The number of particles that had no detectable L1 signal intensity at 1 h compared 36 h co-localized with the TGN as a percentage of total particles counted. ((F)–(H)) Histograms of
ﬂuorescent signal intensity reported as AU from representative pseudovirions selected from 1 and 36 h. Note strong co-localization of L1 and pseudogenome after 1 h (F) binding
whereas there is reduced L1 signal intensity ((G) and (H)) co-localized with pseudogenome within the TGN after 36 h. Statistical signiﬁcance was determined by Student's t-test
(po0.0001) where 100 particles were analyzed (n¼100).
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protein are retained in the TGN together, presumably in a complex,
unable to escape. One explanation for this could be that the mNLS
region of L2 is required for interacting with a TGN egress factor
that is required to carry the pseudogenome to a subsequent
compartment, such as the endoplasmic reticulum as previously
proposed (Bossis et al., 2005; Lipovsky et al., 2013). Another
explanation is that the mNLS is important for interacting with a
nuclear factor that carries the L2/DNA complex into the nucleus.
Further experiments are required to provide mechanistic insight
into how the L2 protein and viral DNA escape from the TGN. In any
case, our observations clearly demonstrate that an intact mNLS of
the L2 protein is important to establish the pseudoviral infection.
Our lab has previously shown that cyclophilins are required
for the dissociation of the L1 protein from the L2/DNA complex
(Bienkowska-Haba et al., 2009, 2012). We presumed that this
dissociation occurred within the endosome prior to nuclear
delivery as L1 is undetectable in the nucleus. Herein, we found
that inhibiting cyclophilins blocked trafﬁcking of the pseudogen-
ome to the TGN. Therefore, we delineate that cyclophilin activity
facilitates the dissociation of the L1 protein from the L2/DNA
complex prior to trafﬁcking to the TGN. This may be explained by a
couple reasons. First, the L1 protein may have a strong putative
sorting signal which prevents trafﬁcking of the L2/DNA complex to
the TGN until the majority of L1 is removed. Second, the L1 protein
sterically blocks the L2 protein from engaging factors required for
retrograde trafﬁcking. Such engagements may include the inter-
action of the L2 protein with components of the retromer complex,
the dynein light chain, and sorting nexin 17, all of which play roles
in retrograde trafﬁcking (Bergant and Banks, 2013; Florin et al.,
2006; Lipovsky et al., 2013; Schneider et al., 2011). However,
Lipovsky et al. demonstrated by the highly sensitive proximity
ligation assay that the L1 protein is detectable in the TGN. We
therefore compared the L1 signal strength of intact pseudovirions
on the ECM to pseudovirions localized in the TGN. In line with
previous ﬁndings, we also found L1 protein in the TGN co-
localized with the pseudogenome but at reduced levels. A sig-
niﬁcant percentage of pseudogenomes detected within the TGN
had no detectable L1 protein suggesting that L1 has been
Fig. 8. Cyclophilin activity is required prior to trafﬁcking to the TGN. ((A)–(C)) HaCaT cells were infected with HPV16 wild-type (wt), 16L2-R302/5A (302/5), 16L2-GP-N-
R302/5A (GPN-302/5) for 36 h in the presence or absence of 10 mM cyclosporine A (Cs). TGN46 (cyan), EdU-labeled pseudogenome (red), and nucleus (grey) were stained
following the Click-iT reaction cocktail. (D) Co-localization of EdU/TGN46 was quantiﬁed as a percentage of total EdU puncta. Statistical signiﬁcance was determined by
Student's t-test (po0.001) where 50 cells were counted (n¼50). Cells were quantiﬁed from one representative experiment from two biological replicates. Note that
pseudogenome does not co-localize with the TGN in cyclosporine A treated cells after 36 h.
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completely removed from these pseudoviral genomes. Therefore,
these data conﬁrm our previous ﬁndings that CyPs facilitate
dissociating the majority of L1 protein from the L2/DNA complex,
presumably in the endosome, an event that according to data
presented herein are required for trafﬁcking to the TGN. Taken
together, we can speculate the following scenarios. First, cyclo-
philins present in the endosome remove the bulk of the L1 protein
from the L2/DNA complex prior trafﬁcking to the TGN, while the
remainder of the L1 protein is removed by TGN resident cyclophi-
lins (Price et al., 1994). Second, we see an incomplete L1 dissocia-
tion in our system because we are depleting cyclophilins by
infecting with too many virions. Lastly, the presence of L1 protein
physically blocks hidden L2 sorting signals, interactions with
egress factors, or a combination of both that would normally
result in TGN egress. Therefore, only the pseudovirions that have
L1 removed may progress to the nucleus, which may explain why
we see a subset of pseudovirions without L1 protein present in the
TGN for the L2-R302/5A mutant pseuodoviral infection and no
detectable L1 protein in the nucleus for wild-type infection.
Clearly many questions about how HPV trafﬁcs to and escapes
the TGN to deliver its viral genome to the nucleus remain
unanswered. However, the data presented here conﬁrm the results
from previous ﬁndings. Furthermore, we demonstrate that cyclo-
philin activity is required for the transport to the viral genome of
HPV16 to the TGN.
Methods
Cell lines
293TT and HeLa cells were cultured in DMEM supplemented
with 10% FBS and antibiotics. HaCaT cells were grown in low
glucose DMEM containing 5% FBS and antibiotics.
Antibodies
HPV16 L1-speciﬁc mouse monoclonal antibody (MAb) 33L1-7,
HPV16 312F, polyclonal rabbit antibody K75, and HPV16 L2-
speciﬁc antibody 33L2-1 have been described. For the detection
of HPV18 L1 protein, L1-speciﬁc mouse MAb 28F was used. H16.V5
was a kind gift from N. D. Christensen, Hershey Medical Center.
Click-iT EdU imaging kit, Alexa Fluor (AF)-labeled secondary
antibodies, and phalloidin were used in immunoﬂuorescent
microscopy (Invitrogen). Peroxidase-conjugated AfﬁniPure goat
anti-mouse and anti-rabbit antibodies were used for Western blot
analysis (Jackson ImmunoResearch). The trans-Golgi network was
detected using MAb anti-p230 (611280, BD Biosciences) and
polyclonal sheep anti-TGN46 (AHP500GT, AbD Serotec). The PML
protein was detected using polyclonal rabbit anti-PML (AB1370,
Chemicon Interntional) and nuclear pore complex using MAb anti-
NUP153 (MMS-102P, Covance). The cell surface was detected using
rabbit polyclonal anti-Caveolin-1 (ab2910, abcam) and Alexa Fluor
647-conjugated Phallodin toxin (A22287, Invitrogen).
Generation of mutations
Point mutations in L2 were generated by site-directed muta-
genesis using pairs of complementary PCR primers speciﬁc to
codon-optimized plasmid puf16L2HA-30 using the PfuUltra II
Hotstart DNA Polymerase 2 Master Mix (#600630, Stratagene)
following manufacturer's protocol. The entire plasmid is ampliﬁed
during the PCR reaction, and the PCR products were digested with
Dpn1 to remove methylated template DNA. The PCR products were
transformed and the mutations were conﬁrmed by sequencing
(SeqWright).
HPV16 pseudovirus generation, viral genome equivalence, and
infection assays
Pseudovirus harboring encapsidated pEGFP-C1 plasmid was
generated using the 293TT cell line as previously described (Buck
and Thompson, 2007; Buck et al., 2005b) using the plasmids
puf16L1 and puf16L2HA-30. Virions were characterized by L1-
and L2-speciﬁc Western blot using mouse monoclonal antibodies
312F and 33L2-1, respectively. The viral DNAwas isolated using the
DNeasy Blood & Tissue kit according to manufacturer's instruc-
tions (69504, Qiagen) supplemented with 4 mM Ethylenediamine-
tetraacetic acid (EDTA) and Dithiothreitol (DTT). The viral genome
equivalent (vge) was determined by real-time PCR. No signiﬁcant
differences were observed with regard to packaging, plasmid
encapsidation, and L2 incorporation among the L2 mutant proteins
characterized herein. For pseudogenome detection by immuno-
ﬂuorescence, pseudogenome was labeled by supplementing
growth media with 100 mM 5-ethynyl-20-deoxyuridine (EdU) at
6 hptx as described (11) during generation of pseudovirus. For
infection assays, same amount of vge was used to infect 293TT
cells and monitored by ﬂow cytometry at 72 h (data not shown).
Infectivity was measured by infecting HaCaT and 293TT cells with
the same amount of vge. After 72 h, the total RNA was isolated
using TRIzol, which was followed by the isolation of mRNA using
GenElute™ mRNA Miniprep Kit (MRN70, Sigma) according to
manufacturer's protocol. The cDNA was synthesized and the
amount of GFP transcript was measured by real-time PCR.
Transfection of expression plasmids and immunoﬂuorescence
HeLa cells were grown on glass cover slips in 6-well plates and
transfected with 3 mg of indicated L2 expression plasmid in serum-
free medium using MATra reagent (#7-2001-100, IBA) according
to manufacturer's protocol. After 24 hptx, whole-cell lysates were
collected and L2 protein expression was detected by Western blot
analysis. For the immunoﬂuorescence in the presence of Lepto-
mycin B (LMB) (L2913, Sigma), 10 ng/ml LMB was added at 0 hptx
and cells were stained at 20 hptx. At the indicated times post-
transfection, cells grown on coverslips were washed with PBS and
ﬁxed with ethanol. Next, slides were washed and blocked with 5%
goat serum in PBS for 30 min, followed by 1 h incubation with
primary antibodies. After extensive washing, cells were incubated
with AlexaFluor-tagged secondary antibodies for 1 h. After exten-
sive washing with PBS, cells were mounted with ProLongs Gold
and SlowFadesAntifade. Groups of cells were counted between 50
and 100 cells in total on single-slice images captured by ﬂuores-
cence microscopy using Images were captured by ﬂuorescence
microscopy using Leica DBMI6000 or Zeiss LSM 510. Images were
all enhanced uniformly using Adobe Photoshop.
Enzyme linked immunosorbent assay (ELISA)
Pseudovirions were diluted in phosphate-buffered saline (PBS),
added to a 96-well plate (Nunc-Immuno Module, Nunc) in
triplicate, and bound for 1 h at 37 1C. Wells were washed with
PBS—0.2% Tween 20 (PBST) and blocked with 0.01% bovine serum
albumin (BSA) in PBST for 1 h at 37 1C. Wells were incubated with
primary antibodies polyclonal rabbit antibody K75, MAb 33L1-7
and MAb H16.V5 for 30 min at 37 1C in a humidity chamber and
subsequently washed with PBST. Wells were incubated with
peroxidase-conjugated anti-mouse or anti-rabbit secondary anti-
body for 30 min at 37 1C in a humidity chamber and subsequently
washed with PBST. The assays were developed with trimethylben-
zidine (Promega) and the reaction was halted by adding 1 M HCl.
Absorbance was measured at 450 nm using a FLUOstar-Omega
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plate reader (BMG Labtech). This experiment was repeated twice
in triplicate and error bars are reported in standard error.
Immunoﬂuorescent microscopy after infection
HaCaT cells were grown on No. 01 coverslips to approximately
50% conﬂuency and infected with HPV16 pseudovirus in the
presence or absence of 10 μM cyclosporine (C988900; Toronto
Research Chemicals). Cells were infected with approximately
1106 to 1107 vge/coverslip. At indicated times post-infection,
coverslips were washed with pH 10.5 PBS for exactly 2 min to
remove any unbound pseudovirus with the exception of
Figs. 3 and 6, ﬁxed with 4% paraformaldehyde (PFA) for 20 min
at room temperature, washed with pH 7.5 PBS, permeabilized with
0.2% Triton X-100 in PBS for 7 min, washed, and blocked with 5%
goat serum or 5% BSA in PBS for 30 min followed by the Click-iT
reaction cocktail containing Alexa Fluor 555 for pseudogenome
detection. After washing, cells were incubated with primary
antibodies in 2.5% goat serum or 5% BSA for 30 min at 37 1C.
We extensively washed and incubated with secondary antibodies
in 2.5% goat serum or 5% BSA for 30 min at 37 1C. We extensively
wash again in PBS and mounted with ProLongs Gold and
SlowFades Antifade containing 40,60-diamidino-2-phenylindole
(DAPI) (P36931; Invitrogen). All images were acquired with a Leica
TCS SP5 Spectral Confocal Microscope. Single slices were quanti-
ﬁed by selecting regions of interest (ROIs) around the TGN and
nucleus and counting co-localization as a percentage of total EdU-
speciﬁc puncta where both channels show an overlapping peak
ﬂuorescent intensity with arbitrary units (AU) greater than 700
(Figs. 6 and 8). Error bars are reported in standard error (n¼50).
Quantiﬁcations are from one representative experiment from
three (Fig. 6) and two (Fig. 8) biological replicates, respectively.
Statistical signiﬁcance was determined using a Student's t-test
(po0.0001) and (po0.001) for Figs. 6 and 8, respectively. Ratio of
L1/EdU was determined by taking the ratio of the peak AU of L1
and EdU at times indicated (Fig. 7). We set a threshold of 300 AU
for all analyses. Any peaks below 300 AU were counted as L1
negative particles. Error bars are reported in standard error
(n¼250). Statistical signiﬁcance was determined using a Student's
t-test (po0.0001). Images were all enhanced uniformly using
Adobe Photoshop.
Cell-binding and uncoating assays
The cell-binding assay was performed by growing HaCaT cells
on coverslips to 50% conﬂuency and binding equal number of
particles for 1 h at 37 1C. Cells were stained as described above
without the pH 10.5 PBS wash and stained with MAb 33L1-7
following Click-iT reaction to denature capsid protein. Assay was
quantiﬁed by taking pixel sum ratio of L1-speciﬁc signal to
caveolin-1. The uncoating assay was performed by growing HaCaT
cells to 50% conﬂuency on coverslips then infected with equal
number of particles for 18 h at 37 1C. Then, cells were stained as
previously described above with MAb 33L1-7 and Alexa Fluor 647
conjugated phallodin without Click-iT reaction cocktail. Uncoating
was quantiﬁed by measuring the pixel sum ratio of the L1- to
actin-speciﬁc signal.
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